Ampbio
Rapid Cell-Based SARS-CoV-2 Neutralizing Antibody Assay Kit
Supplied in India by Ampbio · Research use only
Neutralization Assay Kits

Rapid Cell-Based SARS-CoV-2 Neutralizing Antibody Assay Kit

The entry of SARS-CoV-2 into host cells is mediated by the trimeric transmembrane spike (S) glycoprotein. The S glycoprotein is surface-exposed and mediates entry into the host cells by binding to the human angiotensin-converting enzyme 2 receptor which makes the S glycoprotein a major target of neutralizing antibodies. Neutralizing antibodies blocking the S protein and receptor binding could prevent the virus from infecting host cells.

Variant
Alpha (B.1.1.7)AY4/BA.1 "Deltacron"B.1.1.207B.1.1.298B.1.2B.1.258B.1.494BA.2BA.2.12.1BA.2.75BA.4 and BA.5BA.4.6Beta (B.1.351)BQ.1BQ.1.1CH.1.1D614G Single MutationDelta (B.1.617.2)Delta Plus (AY.2)Delta Plus (AY4.2)DV.7.1.2EG.10.1Epsilon (B.1.427/429)Epsilon (B.1.429)Eta (B.1.525)FL.1.5.1FL.10.1Gamma (P.1)GK.1.1GW.5.1.1HF.1HK.3HV.1HW.1.1JB.2.1JD.1.1JF.1JH.2JN.1JP.1Kappa (B.1.617.1)Lambda (C.37)Mu (B.1.621)Omicron (B.1.1.529)Wild TypeXBB.1XBB.1.16XBB.1.16.11XBB.1.41.1XBB.1.5XBB.1.9.1XBB.2.3
Product Type
96-well Rapid Neutralization Assay Kit - w/ Ready-To-Use Cells
Request a quote

More in Neutralization Assay Kits

Other Virongy products in the same category.

Molecular spheres

Request a Virongy quotation

Tell us the product, variant and pack size you need. We will confirm availability, lead time and pricing for delivery in India.

Connect